Journal Information
Vol. 47. Issue 4.
Pages 195-203 (January 2011)
Share
Share
Download PDF
More article options
Vol. 47. Issue 4.
Pages 195-203 (January 2011)
Review Article
Full text access
Relationship Between Gastro-Oesophageal Reflux and Airway Diseases: The Airway Reflux Paradigm
La relación entre el reflujo gastroesofágico y las enfermedades de la vía aérea: el paradigma del reflujo a vía aérea
Visits
6725
Adalberto Pacheco-Galvána,
Corresponding author
apacheco.hrc@salud.madrid.org

Corresponding author.
, Simon P. Hartb, Alyn H. Moriceb
a Servicio de Neumología, Unidad de Asma y Tos de Difícil Manejo, Hospital Ramón y Cajal, Madrid, Spain
b Cardiovascular and Respiratory Studies, University of Hull, Hull York Medical School, Castle Hill Hospital, Cottingham, UK
This item has received
Article information
Abstract

Our understanding of the relationship between gastro-oesophageal reflux and respiratory disease has recently undergone important changes. The previous paradigm of airway reflux as synonymous with the classic gastro-oesophageal reflux disease (GORD) causing heartburn has been overturned. Numerous epidemiological studies have shown a highly significant association of the acid, liquid, and gaseous reflux of GORD with conditions such as laryngeal diseases, chronic rhinosinusitis, treatment resistant asthma, COPD and even idiopathic pulmonary fibrosis. However, it has become clear from studies on cough hypersensitivity syndrome that much reflux of importance in the airways has been missed, since it is either non- or weakly acid and gaseous in composition. The evidence for such a relationship relies on the clinical history pointing to symptom associations with known precipitants of reflux. The tools for the diagnosis of extra-oesophageal reflux, in contrast to the oesophageal reflux of GORD, lack sensitivity and reproducibility. Unfortunately, methodology for detecting such reflux is only just becoming available and much additional work is required to properly delineate its role.

Keywords:
Airway reflux
Gastro-oesophageal reflux
Non-acid reflux
Chronic cough
Asthma
Resumen

Nuestro conocimiento sobre la relación entre el reflujo gastroesofágico (RGE) y las enfermedades respiratorias ha conllevado recientemente a cambios importantes. El paradigma previo del reflujo a vía aérea (RVA) o RGE que llega hasta la vía aérea como sinónimo de la enfermedad por reflujo gastroesofágico clásica (ERGE) con la pirosis como síntoma imprescindible ha sido definitivamente rechazado. Numerosos estudios epidemiológicos han mostrado una asociación altamente significativa entre el reflujo ácido, líquido y gaseoso de la ERGE con condiciones tales como enfermedades laríngeas, rinosinusitis crónica, asma resistente al tratamiento, EPOC e inclusive fibrosis pulmonar idiopática. Hoy se sabe que gracias a estudios del síndrome de hipersensibilidad tusígena gran parte del reflujo que llega a la vía aérea no es diagnosticado debido a su escaso o nulo contenido de ácido o a su composición gaseosa. La evidencia para esta relación se basa en la historia clínica que señala una asociación sintomática con factores precipitantes conocidos del reflujo. Las exploraciones para el diagnóstico del RA no poseen la sensibilidad o la reproducibilidad que han demostrado las del reflujo esofágico de la ERGE. Desafortunadamente, el acceso a la metodología para la detección de tal reflujo empezó a ser posible hace muy poco tiempo y se requiere aún muchos trabajos de investigación para perfilar correctamente su papel.

Palabras clave:
Reflujo a vía aérea
Reflujo gastroesofágico
Reflujo no ácido
Tos crónica
Asma
Full text is only aviable in PDF
References
[1.]
G.J. Wiener, R. Tsukashima, C. Kelly, E. Wolf, M. Schmeltzer, C.H. Banker, et al.
Oropharyngeal pH monitoring for the detection of liquid and aerosolized supraesophageal gastric reflux.
Journal of Voice, 23 (2009), pp. 498-504
[2.]
J.A. Koufman, J.E. Aviv, R.R. Casiano, G.Y. Shaw.
Laryngopharyngeal reflux: position statement of the committee on speech, voice, and swallowing disorders of the American Academy of Otolaryngology-Head and Neck Surgery.
Otolaryngol Head Neck Surg, 127 (2002), pp. 32-35
[3.]
R. Stovold, I.A. Forrest, P.A. Corris, D.M. Murphy, J.A. Smith, S. Decalmer, et al.
Pepsin, a biomarker of gastric aspiration in lung allografts: a putative association with rejection.
Am J Respir Crit Care Med, 175 (2007), pp. 1298-1303
[4.]
S. Farrell, C. McMaster, D. Gibson, M.D. Shields, W.A. McCallion.
Pepsin in bronchoalveolar fluid: a specific and sensitive method of diagnosing gastro-oesophageal reflux-related pulmonary aspiration.
J Ped Surg, 41 (2006), pp. 289-293
[5.]
K. Blondeau, V. Mertens, B.A. Vanaudenaerde, G.M. Verlenden, D.E. Van Raemdonck, D. Sifrim, et al.
Nocturnal weakly acidic reflux promotes aspiration of bile acids in lung transplant recipients.
J Heart Lung Transplant, 28 (2009), pp. 141-148
[6.]
M.I. Gunnbjörnsdóttir, E. Omenaas, T. Gislason, E. Norrman, A.C. Olin, R. Jogi, et al.
Obesity and nocturnal gastro-oesophageal reflux are related to onset of asthma and respiratory symptoms.
Eur Respir J, 24 (2004), pp. 116-121
[7.]
H.B. El-Serag, A. Sonnenberg.
Comorbid occurrence of laryngeal or pulmonary disease with esophagitis in United States military veterans.
Gastroenterology, 113 (1997), pp. 755-760
[8.]
A.C. Ford, D. Forman, P. Mosyyedi, A.H. Morice.
Cough in the community: a cross sectional survey and the relationship to gastrointestinal symptoms.
Thorax, 61 (2006), pp. 975-979
[9.]
C.E. Rhul, A. Sonnenberg, J.E. Everhart.
Hospitalization with respiratory diseases following hiatal hernia and reflux esophagitis in a prospective, population-based study.
Am J Epidemiol, 11 (2001), pp. 477-483
[10.]
H. Nordenstedt, M. Nilsson, S. Johansson, M.A. Wallander, R. Johnsen, K. Hveen, et al.
The relation between gastro-oesophageal reflux and respiratory symptoms in a population-based study.
Chest, 129 (2006), pp. 1051-1056
[11.]
D. Jaspersen, M. Kulig, J. Labenz, A. Leodolter, T. Lind, K. Meyer-Sabelleck, et al.
Prevalence of extra-oesophageal manifestations in gastro-oesophageal reflux disease: an analysis based on the ProGERD Study.
Aliment Pharmacol Ther, 17 (2003), pp. 1515-1520
[12.]
J. Laitman, J.S. Reidenberg.
The human aerodigestive tract and gastroesophageal reflux: and evolutionary perspective.
Am J Med, 103 (1997), pp. 2S-8S
[13.]
K. Blondeau, L.J. Dupont, V. Mertens, J. Tack, D. Sifrim.
Improved diagnosis of gastrooesophageal reflux in patients with unexplained chronic cough.
Aliment Pharmacol Ther, 25 (2007), pp. 723-732
[14.]
R.N. Patterson, B.T. Johnston, J.E. Ardill, L.G. Heaney, L.P. McGarvey.
Increased tachykinin levels in induced sputum from asthmatic and cough patients with acid reflux.
Thorax, 62 (2007), pp. 491-495
[15.]
G.N. Postma, M.S. Tomek, P.C. Belafsky, J.A. Koufman.
Esophageal motor function in laryngopharyngeal reflux is superior to that in classic gastroesophageal reflux disease.
Ann Otol Rhinol Laryngol, 110 (2001), pp. 1114-1116
[16.]
L. Grossi, A.F. Ciccaglione, L. Marzio.
Transient lower oesophageal sphincter relaxations play an insignificant role in gastro-oesophageal reflux in the proximal oesophagus.
Neurogastroenterol Motil, 13 (2001), pp. 503-509
[17.]
D. Sifrim, R. Holloway.
Transient lower esophageal sphincter relaxations: how many or how harmful?.
Am J. Gastroenterol, 96 (2001), pp. 2529-2532
[18.]
J.E. Pandolfino, S.K. Ghosh, Q. Zhang, A. Han, P.J. Kahrilas.
Upper sphincter function during transient lower oesophageal sphincter relaxation (TLOSR);it is mainly about microburps.
Neurogastroenterol Motil, 19 (2007), pp. 203-210
[19.]
A. Bansal, P.J. Kahrilas.
Has high-resolution manometry changed the approach to esophageal motility disorders?.
Curr Opin Gastroenterol, 26 (2010), pp. 344-351
[20.]
R.E. Knight, J.R. Wells, R.S. Parrish.
Esophageal dysmotility is an important co-factor in extraesophageal manifestations of gastroesophageal reflux.
Laryngoscope, 110 (2000), pp. 1462-1466
[21.]
J.A. Kastelik, A.E. Redington, I. Aziz, G.K. Buckton, C.M. Smith, M. Dakkak, et al.
Abnormal oesophageal motility in patients with chronic cough.
Thorax, 58 (2003), pp. 699-702
[22.]
N.S. Balaji, D. Blom, T.R. DeMeester, J.H. Peters.
Redifining gastroesophageal reflux.
Surg Endosc, 17 (2003), pp. 1380-1385
[23.]
O. Kawamura, M. Aslam, T. Rittmann, C. Hofmann, R. Shaker.
Am J Physical pH properties of gastroesophagopharingeal refluxate:a 24-hour-simultaneous ambulatory impedance and pH monitoring study.
Gastroenterol, 99 (2004), pp. 1000-1010
[24.]
D.S. Oh, J.A. Hagen, M. Fein, C.G. Bremner, C.M. Dunst, S.R. DeMeester, et al.
The impact of reflux composition on mucosal damage and esophageal function.
J Gastroenterol Surg, 10 (2006), pp. 787-797
[25.]
D. Sifrim, S. Castell, J. Dent, P.J. Kahrilas.
Gastro-esophageal reflux monitoring: review and consensus report of a detection and definitions of acid, non acid as gas reflux.
Gut, 53 (2004), pp. 1024-1031
[26.]
N. Johnston, D. Bulmer, G. Gill, M. Panetti, P.E. Ross, J.P. Pearson, et al.
Cell biology of laryngeal epithelial defences in health and disease: further studies.
Ann Otol Rhinol Laryngol, 112 (2003), pp. 481-491
[27.]
N. Johnston, T.L. Samuels, J.H. Blumin.
Pepsin in nonacidic refluxate can damage hypopharyngeal epithelial cells.
Ann Otol Rhinol Laryngol, 118 (2009), pp. 677-685
[28.]
C.I. Jack, M.J. Walshaw, J. Tran, C.R. Hind, C.C. Evans.
Twenty-four-hour tracheal pH monitoring, a simple and non hazardous investigations.
Respir Med, 88 (1994), pp. 441-444
[29.]
S.Y. Phua, L.P. McGarvey, M.C. Ngu, A.J. Ing.
Patients with gastroesophageal reflux disease and cough have impaired laryngopharyngeal mechanosensitivity.
Thorax, 60 (2005), pp. 488-491
[30.]
A. Pauwels, K. Blondeau, L. Dupont, D. Sifrim.
Cough and gastroesophageal reflux: From the gastroenterologist end.
Pulm Pharmacol Ther, 22 (2009), pp. 135-138
[31.]
N. Patterson, I. Meinie, G. Rafferty, L. McGarvey, L. Heaney, R. Tutuian, et al.
Nonacid reflux episodes reaching the pharynx are important factors associated with cough.
J Clin Gastroenterol, 43 (2009), pp. 414-419
[32.]
J.P. Galmiche, F. Zerbib, S. Bruley des Varennes.
Review article: respiratory manifestations of gastro-oesophageal reflux disease.
Aliment Pharmacol Ther, 27 (2008), pp. 449-464
[33.]
M. Ferrari, L. Benini, E. Brotto, F. Locatelli, F. De Loiro, F. Bonella, et al.
Omeprazole reduces the response to capsaicin but not to metacholine in asthmatics patients with proximal reflux.
Scan J Gastroenterol, 42 (2007), pp. 299-307
[34.]
D.N. Wu, K. Yamauchi, H. Kobayashi, Y. Tanifugi, C. Kato, K. Suzuki, et al.
Effects of esophageal acid perfusion on cough responsiveness in patients with bronchial asthma.
Chest, 122 (2002), pp. 505-509
[35.]
P.J. Barnes.
Neurogenic inflammation in the airways.
Respir Physiol, 125 (2001), pp. 145-154
[36.]
N. Vakil, S.V. van Zanten, P. Kahrilas, J. Dent, R. Jones, Global Consensus Group.
The Montreal definition and classification of the gastroesophageal reflux disease.
Am J Gastroenterol, 101 (2006), pp. 1900-1920
[37.]
D. Jaspersen, J. Laenz, S.N. Willich, M. Kulig, M. Nocon, A. Leodolter, et al.
Long-therm clinical course of extra-oesophageal manifestations in patients with gastro-oesophageal reflux disease: a prospective follow-up analysis based on the ProGERD study.
Dig Liver Dis, 38 (2006), pp. 233-238
[38.]
R.S. Irwin, L.P. Boulet, M.M. Cloutier, R. Fuller, P.M. Gold, V. Hoffstein, et al.
Managing cough as a defense mechanism and as a symptom. A Consensus Panel report of the American College of Chest Physicians.
Chest, 114 (1998), pp. 133S-181S
[39.]
T.O. Kiljander, E.R. Salomaa, E.K. Hietanen, E.O. Terho.
Chronic cough and gastroesophageal reflux: a double-blind placebo-controlled study with omeprazole.
Eur Respir J, 16 (2000), pp. 633-638
[40.]
P.L. Kamel, D. Hanson, P.J. Kahrilas.
Prospectve trial of omeprazole in the treatment of posterior laryngitis.
Am J Med, 96 (1994), pp. 321-326
[41.]
S.K. Field, L.R. Sutherland.
Does medical antireflux therapy improve asthma in asthmatics with gastroesophageal reflux? A critical review of the literature.
Chest, 114 (1998), pp. 275-283
[42.]
S.J. Sontag, S. ÓConnell, S. Khandelwal, H. Greenlee, T. Schnell, B. Nemchausky, et al.
Asthmatics with gastro-esophageal reflux: Long term results of a randomised trial of medical and surgical antireflux therapies.
Am J Gastroenterol, 98 (2003), pp. 987-999
[43.]
A. De Diego Damiá, V. Plaza Moral, V. Garrigues Gil, J.L. Izquierdo Alonso, A. López Viña, J. Mullol Miret, et al.
Tos crónica. Normativa Separ.
Arch Bronconeumol, 38 (2002), pp. 236-245
[44.]
P. Pontes, R. Tiago.
Diagnosis and management of laryngopharyngeal reflux disease.
Curr Opin Otolaryngol Head Neck Surg, 14 (2006), pp. 138-142
[45.]
P.D. Karkos, J. Benton, S.C. Leong, A. Karkanevatos, K. Badran, V.R. Srinivasan, et al.
Trends in laryngopharyngeal reflux: a British ENT survey.
Eur Arch Othorhinolaryngol, 264 (2007), pp. 513-517
[46.]
C.F. Everett, A.H. Morice.
Clinical history in gastroesophageal cough.
Respir Med, 101 (2007), pp. 345-348
[47.]
A.J. Bredenoord, B.L. Weusten, R. Timmer, A.J. Smout.
Characteristics of gastroesophageal reflux in symptomatic patients with and without excessive esophageal acid exposure.
Am J Gastroenterol, 101 (2006), pp. 2470-2475
[48.]
F. Zerbib, A. Duriez, S. Roman, M. Capdepont, F. Mion.
Determinants of gastrooesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors.
[49.]
P.C. Belafsky, C.J. Rees, K. Rodríguez, J.S. Pryor, P.O. Katz.
Esophagopharyngeal reflux.
Otolaryngol Head Neck Surg, 138 (2008), pp. 57-61
[50.]
M.C. Aanen, B.L. Weusten, M.E. Numans, N.J. de Wit, A. Baron, A.J. Smout.
Diagnostic value of the proton pump inhibitor test for gastroesophageal reflux disease in primary care.
Aliment Pharmacol Ther, 24 (2006), pp. 1377-1384
[51.]
A.L. Merati, H.J. Lim, S.O. Ulualp, R.J. Toohill.
Meta-analysis of upper probe measurement in normal subjects and patients with laryngopharyngeal reflux.
Ann Otol Rhinol Laryngol, 114 (2005), pp. 177-182
[52.]
M.F. Vaezy.
Sensitivity and specificity of reflux-attributed laryngeal lesions: experimental and clinical evidence.
Am J Med, 115 (2003), pp. 97S-104S
[53.]
B.K. Oelschlager, L. Chang, C.E. Pope, C.A. Pellegrini.
Typical GERD, symptoms and esophageal pH monitoring are not enough to diagnose pharyngeal reflux.
J Surg Res, 128 (2005), pp. 55-60
[54.]
I. Mainie, R. Tutuian, S. Shay, M. Vela, X. Zhang, D. Sifrim, et al.
Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring.
Gut, 55 (2006), pp. 1398-1402
[55.]
F. Zerbib, S. Roamn, A. Ropert, S.B. des Varannes, P. Pouderoux, U. Chaput, et al.
Esophageal pH-impedance monitoring and symptoms analysis in GERD: a study in patients off and on therapy.
Am J Gastroenterol, 101 (2006), pp. 1956-1963
[56.]
H.N. Nguyen, J. Silny, S. Matern.
Multiple intraluminal electrical impedancemetry for recording of upper gastrointestinal motility. Current results and further implications.
Am J Gastroenterol, 94 (1999), pp. 306-317
[57.]
R. Tutuian, M.F. Vela, E.G. Hill, I. Mainie, A. Agrawal, D.O. Castell.
Characteristics of symptomatic reflux episodes on acid suppressive therapy.
Am J Gastroenterol, 103 (2008), pp. 1090-1096
[58.]
N. Sharma, A. Agrawal, J. Freeman, M.F. Vela, D. Castell.
An analysis of persisting symptoms in acid-suppressed patients undergoing impedance-pH monitoring.
Clin Gastroenterol Hepatol, 6 (2008), pp. 521-524
[59.]
J.M. Wo, J. Koopman, S.P. Harrell, K. Parker, W. Winstead, E. Lentsch.
Double-blind placebo-controlled trial with single-dose pantoprazole for laryngopharyngeal reflux.
Am J Gastroenterol, 101 (2006), pp. 1972-1978
[60.]
M. Cool, J. Poelsmans, L. Feenstra, J. Tack.
Characteristics and clinical relevance of proximal esophageal pH monitoring.
Am J Gastroenterol, 99 (2004), pp. 2317-2323
[61.]
Wolf E. Self-condensing pH sensor. US Patent Number 7,166,201. January 23, 2007. Sierra Medical Technology, Inc.
[62.]
S. Ayazi, J.C. Lipham, J.A. Hagen, A.L. Tang, J. Zehetner, J.A. Leers, et al.
A new technique for measurement of pharyngeal pH: normal values and discriminating pH threshold.
J Gastrointest Surg, 13 (2009), pp. 1422-1429
[63.]
J. Knight, M.O. Lively, N. Johnston, P.W. Dettmar, J.A. Koufman.
Sensitive pepsin immunoassay for detection of laryngopharyngeal reflux.
Laryngoscope, 115 (2005), pp. 1473-1478
[64.]
B.C. Jacobson, S.C. Somers, C.S. Fuchs, C.P. Kelly, C.A. Camargo.
Body-mass index and symptoms of gastroesophageal reflux in women.
N Engl J Med, 354 (2006), pp. 2340-2348
[65.]
A.B. Chang, T.J. Lasserson, J. Gaffney, F.L. Connor, L.A. Garske.
Gastrooesophageal relux treatment for prolonged non-specific cough in children and adults.
Cochrane Database Syst Rev, 4 (2006),
[66.]
R.S. Irwin.
Chronic cough due to gastroesophageal reflux disease: ACCP evidence-based clinically practice guidelines.
Chest, 129 (2006), pp. S80-S94
[67.]
A.H. Morice, G.A. Fontana, M.G. Belvisi, S.S. Birring, K.F. Chung, P.V. Dicpinigaitis, et al.
ERS guideliness on the assessment of cough.
Eur Respir J, 29 (2007), pp. 1256-1276
[68.]
M.A. Qadeer, C.O. Philips, A.R. López, D.L. Steward, J.O. Noordzij, J.M. Wo, et al.
Proton pump inhibitor therapy for suspected GER-related laryngitis: a meta-analysis of randomized controlled trials.
Am J Gastroenterol, 101 (2006), pp. 2646-2654
[69.]
W. Park, D.M. Hicks, F. Khandwala, J.E. Richter, T.I. Abelson, C. Milstein, et al.
Laryngopharynegeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response.
Laryngoscope, 115 (2005), pp. 1230-1238
[70.]
F. Baldi, R. Capiello, C. Cavoli, S. Ghersi, F. Torresan, E. Rodar.
Proton pump inhibitor treatment of patients with gastroesophageal reflux-related chronic cough: a comparison between two different daily dose of lansoprazole.
World J Gastroenterol, 12 (2006), pp. 82-88
[71.]
J.P. Parsons, J.G. Mastronade.
Gastroesophageal reflux disease and asthma.
Curr Opin Pulm Med, 16 (2010), pp. 60-63
[72.]
J.G. Mastronade, N.R. Anthonisen, M. Castro, J.T. Holbrook, F.T. Leone, W.G. Teague, et al.
Efficacy of esomeprazole for treatment of poorly controlled asthma.
N Engl J Med, 360 (2009), pp. 1487-1499
[73.]
National Asthma Education and Prevention Program. Expert Panel Report: Guideliness for the Diagnosis and Management of Asthma-Summary Report 2007.
J Allergy Clin Immunol, 120 (2007), pp. S94-S138
[74.]
M.A. Qadeer, J. Swoger, C. Milstein, D.M. Hicks, J. Ponsky, J.E. Richter, et al.
Correlation between symptoms and laryngeal signs in laryngopharyngeal reflux.
Laryngoscope, 115 (2005), pp. 1947-1952
[75.]
M.F. Vaezi, J.E. Richter, C.R. Stasney, J.R. Spiegel, R.A. Iannuzzi, J.A. Crawley, et al.
Treatment of chronic posterior laryngitis with esomeprazole.
Laryngoscope, 116 (2006), pp. 254-260
[76.]
B.J. Canning, S.B. Mazzone.
Reflex mechanisms in gastroesophageal reflux disease and asthma.
Am J Med, 115 (2003), pp. S45-S48
[77.]
Y.M. Fouad, P.O. Katz, D.O. Castell.
Oesophageal motility defects associated with nocturnal gastro-oesophageal reflux on proton pump inhibitors.
Aliment Pharmacol Ther, 13 (1999), pp. 1467-1471
[78.]
J.C. Fang, I. Sarosiek, Y. Yamamoto, J. Liu, R.K. Mittal.
Cholinergic blockade inhibits gastro-oesophageal reflux and transient lower oesophageal sphincter relaxation through a central mechanism.
Gut, 44 (1999), pp. 603-607
[79.]
L.A. Blackshaw.
New insights in the neural regulation of the lower oesophageal sphincter.
Eur Rev Med Pharmacol Sci, 12 (2008), pp. 33-39
[80.]
R.H. Holloway.
Systemic pharmacomodulation of transient lower sphincter relaxations.
Am J Med, 111 (2001), pp. 178S-185S
[81.]
A.J. Bredenoord.
Lesogaberan, a GABA (B) agonist for the potential treatment of gastroesophageal reflux disease.
Drugs, 12 (2009), pp. 576-584
[82.]
R.H. Poe, M.C. Kallay.
Chronic cough and gastroesophageal reflux disease: experience with specific therapy for diagnosis and treatment.
Chest, 123 (2003), pp. 679-684
[83.]
K. Blondeau, V. Mertens, B.M. Vanaudenaerde, G. Verleden, D. Van Raendonck, L. Dupont, et al.
The macrolide antibiotic azithromycin reduces gastroesophageal reflux in lung transplant patients.
Gastroenterology, 132 (2007), pp. A594
[84.]
V. Mertens, K. Blondeau, B.M. Vanaudenaerde, R. Vos, D.E. Van Raemdonk, G.M. Verleden, et al.
Azithromicyn reduces bile acid aspiration in lung transplant recipients.
J Heart Lung Transplant, 27 (2008), pp. S124
[85.]
J.A. Todd, K.K. Basu, J.S. de Caestecker.
Normalization of oesophageal pH does not guarantee control of duodenogastro-oesophageal reflux in Barret's esophagus.
Aliment Pharmacol Ther, 21 (2005), pp. 969-975
[86.]
M.I. Booth, L. Jones, J. Stratford, T.C. Dehn.
Results of laparoscopic Nissen fundoplication at 2–8 years after surgery.
[87.]
B.K. Oelschlager, C.A. Pellegrini.
Minimally invasive surgery for gastroesophageal reflux disease.
J Laparoendosc Adv Surg Tech A, 11 (2001), pp. 341-349
[88.]
J.A. Kaufman, J.E. Houghland, M. Quiroga, C.A. Cahill, C.A. Pellegrini, B.K. Oelschlager.
Long-term outcomes of laparoscopic antireflux surgery for gastroesophageal reflux disease (GERD)-related airway disorders.
Surg Endosc, 20 (2006), pp. 1824-1830
[89.]
U. Krishnan, J.D. Mitchell, I. Messina, A.S. Day, T.D. Bohane.
Assay of tracheal pepsin as a marker of reflux aspiration.
J Pediatr Gastroenterol Nutr, 35 (2002), pp. 303-308
[90.]
M. Iqbal, A.J. Batch, R.T. Spychal, B.T. Cooper.
Outcome of surgical fundoplication for extraesophageal (atypical) manifestations of gastroesophageal reflux disease in adults: a systematic review.
J Laparoendosc Adv Surg Tech A, 18 (2008), pp. 789-796
[91.]
K. Gleeson, D.F. Eggli, S.L. Maxwell.
Quantitative aspiration during sleep in normal subject.
Chest, 111 (1997), pp. 1266-1272
[92.]
M.G. Patti, H.T. Debas, C.A. Pellegrini.
Esophageal manometry and 24-hour pH monitoring in the diagnosis of pulmonary aspiration secondary to gastroesophageal reflux.
Am J Surg, 163 (1992), pp. 401-406
[93.]
R.D. Gross, C.W. Atwood, S.B. Ross, J.W. Olszewski, K.A. Eichhorn.
The coordination of breathing and swallowing in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 179 (2009), pp. 559-565
[94.]
K. Terada, S. Muro, T. Ohara, M. Kudo, E. Ogawa, Y. Hoshino, et al.
Abnormal swallowing reflex and COPD exacerbations.
Chest, 137 (2010), pp. 326-332
[95.]
S.M. Harding.
Gastroesophageal reflux and asthma: insight into the association.
J Allergy Clin Immunol, 104 (1999), pp. 251-259
[96.]
L.A. Pérez de Llano, F. Carballada, O. Castro, M. Pizarro, M. Vázquez, A. Baloira.
Relación entre presencia de comorbilidad y control del asma.
Arch Bronconeumol, 46 (2010), pp. 508-513
[97.]
R.R. Kempainen, K. Savik, T.P. Whelan, J.M. Dunitz, C.S. Herrington, J.L. Billings.
High prevalence of proximal and distal gastroesophageal reflux disease in advanced COPD.
Chest, 131 (2007), pp. 1666-1671
[98.]
C. Casanova, J.S. Baudet, M. del Valle Velasco, J.M. Martín, A. Aguirre-Jaime, J.P. De Torres, et al.
Increased gastro-oesophageal reflux disease with severe COPD.
Eur Respir J, 23 (2004), pp. 841-845
[99.]
E. Eryuksel, M. Dogan, S. Olgun, I. Kocak, T. Celikel.
Incidence and treatment results of laryngopharyngeal reflux in chronic obstructive pulmonary disease.
Eur Arch Otorhinolaryngol, 266 (2009), pp. 1267-1271
[100.]
R. Shaker, D.O. Castell, P.S. Schoenfeld, S.J. Spechler.
Nighttimes heartburn is underappreciated clinical problem that impacts sleep and daytime function: the results of a Gallup survey conducted on behalfof the American Gastroenterological Association.
Am J Gastroenterol, 98 (2003), pp. 1487-1493
[101.]
D.A. Jonhson, W.C. Orr, J.A. Crawley, B. Traxler, J. McCullough, K.A. Brown, et al.
Effect of esomeprazol on night time heartburn and sleep quality in patients with GERD: a randomised placebo-controlled trial.
Am J Gastroenterol, 100 (2005), pp. 1914-1922
[102.]
S. Kuribayashi, B.T. Massey, M. Hafeezullah, L. Perera, S.Q. Hussaini, L. Tatro, et al.
Upper esophageal sphincter and gastroesophageal junction pressure changes act to prevent gastroesophageal and esophagopharyngeal reflux during apneic episodes in patients with obstructive sleep apnea.
Chest, 137 (2010), pp. 769-776
[103.]
K.K.Y. Chang, A.J. Ing, L. Laks, G. Cossa, P. Rogers, S.S. Birring.
Chronic cough in patients with sleep disorders breathing.
Eur Respir J, 35 (2010), pp. 368-372
[104.]
K.M. Sundar, S.E. Daly, M.J. Pearce, W.T. Alward.
Chronic cough and obstructive sleep apnea in a community-based pulmonary practice.
[105.]
G. Raghu, T.D. Freudenerger, S. Yang, J.R. Curtis, C. Spada, J. Hayes, et al.
High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis.
Eur Respir J, 27 (2006), pp. 136-142
[106.]
K. Blondeau, L.J. Dupont, V. Mertens, G. Verleden, A. Malfroot, B. Vandenplas, et al.
Gastro-oesophageal reflux and aspiration of gastric contents in adult patients with cystic fibrosis.
Gut, 57 (2008), pp. 1049-1055
[107.]
J.L. Bobadilla, E. Jankowska-Gan, Q. Xu, L.D. Haynes, A. Muñoz del Río, K. Meyer, et al.
Reflux induced collagen type V sensitization: potential mediator of bronchiolitis obliterans syndrome.
Chest, 138 (2010), pp. 363-370
Copyright © 2011. Sociedad Española de Neumología y Cirugía Torácica
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?